JOURNAL OF BUON, vol.18, no.2, pp.314-320, 2013 (SCI-Expanded)
Purpose: Anthracyclines and taxanes are the most active agents in the adjuvant treatment of breast cancer (BC). They can be used simultaneously or sequentially. The optimal schedule and duration for their administration is unknown. We analyzed the efficacy of sequential adjuvant anthracycline and docetaxel administration in node positive BC patients.